Preventive Nutrition and Food Science

The Korean Society of Food Science and Nutrition (한국식품영양과학회)
권호 표지
DOI QR코드

DOI QR Code

Anti-Helicobacter pylori Properties of GutGardTM

  • Kim, Jae Min (National Center of Efficacy Evaluation for the Development of Health Products Targeting Digestive Disorder, Inha Hospital) ;
  • Zheng, Hong Mei (National Center of Efficacy Evaluation for the Development of Health Products Targeting Digestive Disorder, Inha Hospital) ;
  • Lee, Boo Yong (Department of Food Science & Biotechnology, CHA University) ;
  • Lee, Woon Kyu (National Center of Efficacy Evaluation for the Development of Health Products Targeting Digestive Disorder, Inha Hospital) ;
  • Lee, Don Haeng (National Center of Efficacy Evaluation for the Development of Health Products Targeting Digestive Disorder, Inha Hospital)
  • Received : 2013.04.01
  • Accepted : 2013.04.15
  • Published : 2013.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

Presence of Helicobacter pylori is associated with an increased risk of developing upper gastrointestinal tract diseases. Antibiotic therapy and a combination of two or three drugs have been widely used to eradicate H. pylori infections. Due to antibiotic resistant drugs, new drug resources are needed such as plants which contain antibacterial compounds. The aim of this study was to investigate the ability of GutGard$^{TM}$ to inhibit H. pylori growth both in Mongolian gerbils and C57BL/6 mouse models. Male Mongolian gerbils were infected with the bacteria by intragastric inoculation ($2{\times}10^9$ CFU/gerbil) 3 times over 5 days and then orally treated once daily 6 times/week for 8 weeks with 15, 30 and 60 mg/kg GutGard$^{TM}$. After the final administration, biopsy samples of the gastric mucosa were assayed for bacterial identification via urease, catalase and ELISA assays as well as immunohistochemistry (IHC). In the Mongolian gerbil model, IHC and ELISA assays revealed that GutGard$^{TM}$ inhibited H. pylori colonization in gastric mucosa in a dose dependent manner. The anti-H. pylori effects of GutGard$^{TM}$ in H. pylori-infected C57BL/6 mice were also examined. We found that treatment with 25 mg/kg GutGard$^{TM}$ significantly reduced H. pylori colonization in mice gastric mucosa. Our results suggest that GutGard$^{TM}$ may be useful as an agent to prevent H. pylori infection.

Keywords

References

  1. Marshall JB. 2001. One hundred years of discovery and rediscovery of Helicobacter pylori and its association with peptic ulcer disease. In Helicobacter pylori: Physiology and Genetics. Mobley HLT, Mendz GL, Hazell SL, eds. ASM Press, Washington, DC, USA. p 19-24.
  2. Hunt RH, Xiao SD, Megraud F, Leon-Barua R, Bazzoli F, Van der Merwe S, Vaz Coelho LG, Fock M, Fedail S, Cohen H, Malfertheiner P, Vakil N, Hamid S, Goh KL, Wong BCY, Krabshuis J, Le Mair A. 2011. Helicobacter pylori in developing countries. J Gastrointestin Liver Dis 20: 299-304.
  3. Nomura A, Stemmermann GN, Chyou PH, Perez-Perez GI, Blaser MJ. 1994. Helicobacter pylori infection and the risk for duodenal and gastric ulceration. Ann Intern Med 120: 977-981. https://doi.org/10.7326/0003-4819-120-12-199406150-00001
  4. Adamu MA, Schottker B, Weck MN, Brenner H. 2012. Helicobacter pylori infection is strongly associated with gastric and duodenal ulcers in a large prospective study. Clin Gastroenterol Hepatol 10: 487-493. https://doi.org/10.1016/j.cgh.2011.12.036
  5. Fuccio L, Zagari RM, Eusebi LH, Laterza L, Cennamo V, Ceroni L, Grilli D, Bazzoli F. 2009. Meta-analysis: can Helicobacter pylori eradication treatment reduce the risk forgastric cancer? Ann Intern Med 151: 121-128. https://doi.org/10.7326/0003-4819-151-2-200907210-00009
  6. Montalban C, Castrillo MJ, Abraira V, Serrano M, Bellas C, Piris MA, Carrion R, Cruz MA, Laraña JG, Menarguez J, Gomez-Marcos F, Rivas C. 1995. Gastric B-cell mucosaassociated lymphoid tissue (MALT) lymphoma. Clinicopathological study and evaluation of the prognostic factors in 143 patients. Ann Oncol 6: 355-362. https://doi.org/10.1093/oxfordjournals.annonc.a059184
  7. Owens SR, Smith LB. 2011. Molecular aspects of H. pylorirelated MALT lymphoma. Patholog Res Int 2011: 193149.
  8. Malfertheiner P, Megraud F, O'Morain C, Bazzoli F, El-Omar E, Graham D, Hunt R, Rokkas T, Vakil N, Kuipers EJ. 2007. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut 56: 772-781. https://doi.org/10.1136/gut.2006.101634
  9. Chey WD, Wong BC. 2007. American College of Gastroenterology guideline on the management of Helicobacter pylori infection. Am J Gastroenterol 102: 1808-1825. https://doi.org/10.1111/j.1572-0241.2007.01393.x
  10. Fischbach L, Evans EL. 2007. Meta-analysis: the effect of antibiotic resistance status on the efficacy of triple and quadruple first-line therapies for Helicobacter pylori. Aliment Pharmacol Ther 26: 343-357. https://doi.org/10.1111/j.1365-2036.2007.03386.x
  11. De Francesco V, Giorgio F, Hassan C, Manes G, Vannella L, Panella C, Ierardi E, Zullo A. 2010. Worldwide H. pylori antibiotic resistance: a systematic review. J Gastrointestin Liver Dis 19: 409-414.
  12. Basset C, Holton J, Gatta L, Ricci C, Bernabucci V, Liuzzi G, Vaira D. 2004. Helicobacter pylori infection: anything new should we know? Aliment Pharmacol Ther 2: 31-41.
  13. Mégraud F. 2004. H pylori antibiotic resistance: prevalence, importance, and advances in testing. Gut 53: 1374-1384. https://doi.org/10.1136/gut.2003.022111
  14. O'Mahony R, Al-Khtheeri H, Weerasekera D, Fernando N, Vaira D, Holton J, Basset C. 2005. Bactericidal and antiadhesive properties of culinary and medicinal plants against Helicobacter pylori. World J Gastroenterol 11: 7499-7507. https://doi.org/10.3748/wjg.v11.i47.7499
  15. Lata S, Kakkar S, Srivastava VK, Saxena KK, Saxena RS, Kumar A. 1999. Comparative antipyretic activity of Ocimum sanctum, Glycyrrhiza glabra and aspirin in experimentallyinduced pyrexia in rats. Indian J Pharmacol 31: 71-75.
  16. Wittschier N, Faller G, Hensel A. 2009. Aqueous extracts and polysaccharides from liquorice roots (Glycyrrhiza glabra L.) inhibit adhesion of Helicobacter pylori to human gastric mucosa. J Ethnopharmacol 125: 218-223. https://doi.org/10.1016/j.jep.2009.07.009
  17. Dong S, Inoue A, Zhu Y, Tanji M, Kiyama R. 2007. Activation of rapid signaling pathways and the subsequent transcriptional regulation for the proliferation of breast cancer MCF-7 cells by the treatment with an extract of Glycyrrhiza glabra root. Food Chem Toxicol 45: 2470-2478. https://doi.org/10.1016/j.fct.2007.05.031
  18. Gupta VK, Fatima A, Faridi U, Negi AS, Shanker K, Kumar JK, Rahuja N, Luqman S, Sisodia BS, Saikia D, Darokar MP, Khanuja SP. 2008. Antimicrobial potential of Glycyrrhiza glabra roots. J Ethnopharmacol 116: 377-380. https://doi.org/10.1016/j.jep.2007.11.037
  19. Lakworthy W, Holgate PF. 1975. Deglycyrrhizinized liquorice in the treatment of chronic duodenal ulcer. A retrospective endoscopic survey of 32 patients. Practitioner 215: 787-792.
  20. Feldman RA. 2001. Epidemiologic observations and open questions about disease and infection caused by Helicobacter pylori. In Helicobacter pylori: Molecular and Cellular Biology. Achtman M, Suerbaum S, eds. Horizon Scientific Press, Wymondham, United Kingdom. p 29-51.
  21. Chandrasekaran CV, Sundarajan K, Gupta A, Srikanth HS, Edwin J, Agarwal A. 2011. Evaluation of the genotoxic potential of standardized extract of Glycyrrhiza glabra (GutGardTM). Regul Toxicol Pharmacol 61: 373-380. https://doi.org/10.1016/j.yrtph.2011.10.002
  22. Raveendra KR, Jayachandra, Srinivasa V, Sushma KR, Allan JJ, Goudar KS, Shivaprasad HN, Venkateshwarlu K, Geetharani P, Sushma G, Agarwal A. 2012. An extract of Glycyrrhiza glabra (GutGard) alleviates symptoms of functional dyspepsia: a randomized, double-blind, placebo-controlled study. Evid Based Complement Alternat Med 2012: 216970.
  23. Mukherjee M, Bhaskaran N, Srinath R, Shivaprasad HN, Allan JJ, Shekhar D, Agarwal A. 2010. Anti-ulcer and antioxidant activity of GutGard. Indian J Exp Biol 48: 269-274.
  24. Golden SA, Covington HE 3rd, Berton O, Russo SJ. 2011. A standardized protocol for repeated social defeat stress in mice. Nat Protoc 6: 1183-1191. https://doi.org/10.1038/nprot.2011.361
  25. Hernández F, Rivera P, Sigarán M, Miranda J. 1991. Diagnosis of Helicobacter pylori: comparison of a urease test, histological visualization of curved bacteria and culture. Rev Inst Med Trop Sao Paulo 33: 80-82. https://doi.org/10.1590/S0036-46651991000100015
  26. Ddd Li GQ, Xia HH, Chen MH, Gu Q, Wang JD, Peng JZ, Chan AOO, Cho CH, So HL, Lam SK, Hu PJ, Liang YJ, Lin HL, Berg DE, Feng ZH, Langenbach R, Wong BCY. 2006. Effects of cyclooxygenase-1 and -2 gene disruption on Helicobacter pylori-induced gastric inflammation. J Infect Dis 193: 1037- 1046. https://doi.org/10.1086/500984
  27. Nozaki K, Shimizu N, Ikehara Y, Inoue M, Tsukamoto T, Inada K, Tanaka H, Kumagai T, Kaminishi M, Tatematsu M. 2003. Effect of early eradication on Helicobacter pylori-related gastric carcinogenesis in Mongolian gerbils. Cancer Sci 94: 235-239. https://doi.org/10.1111/j.1349-7006.2003.tb01426.x
  28. Lee JH, Park EK, Uhm CS, Chung MS, Kim KH. 2004. Inhibition of Helicobacter pylori adhesion to human gastric adenocarcinoma epithelial cells by acidic polysaccharides from Artemisia capillaris and Panax ginseng. Planta Med 70: 615-619. https://doi.org/10.1055/s-2004-827183
  29. Shmuely H, Burger O, Neeman I, Yahav J, Samra Z, Niv Y, Sharon N, Weiss E, Athamna A, Tabak M, Ofek I. 2004. Susceptibility of Helicobacter pylori isolates to the antiadhesion activity of a high-molecular-weight constituent of cranberry. Diagn Microbiol Infect Dis 50: 231-235. https://doi.org/10.1016/j.diagmicrobio.2004.08.011
  30. Ikeno T, Ota H, Sugiyama A, Ishida K, Katsuyama T, Genta RM, Kawasaki S. 1999. Helicobacter pylori-induced chronic active gastritis, intestinal metaplasia, and gastric ulcer in Mongolian gerbils. Am J Pathol 154: 951-960. https://doi.org/10.1016/S0002-9440(10)65343-6
  31. Matsubara S, Shibata H, Ishikawa F, Yokokura T, Takahashi M, Sugimura T, Wakabayashi K. 2003. Suppression of Helicobacter pylori-induced gastritis by green tea extract in Mongolian gerbils. Biochem Biophys Res Commun 310: 715-719. https://doi.org/10.1016/j.bbrc.2003.09.066
  32. Raghavan S, Hjulström M, Holmgren J, Svennerholm AM. 2002. Protection against experimental Helicobacter pylori infection after immunization with inactivated H. pylori whole-cell vaccines. Infect Immun 70: 6383-6388. https://doi.org/10.1128/IAI.70.11.6383-6388.2002
  33. Iimuro M, Shibata H, Kawamori T, Matsumoto T, Arakawa T, Sugimura T, Wakabayashi K. 2002. Suppressive effects of garlic extract on Helicobacter pylori-induced gastritis in Mongolian gerbils. Cancer Lett 187: 61-68. https://doi.org/10.1016/S0304-3835(02)00401-9

Cited by

  1. Challenges to the Treatment and New Perspectives for the Eradication of Helicobacter pylori vol.60, pp.10, 2015, https://doi.org/10.1007/s10620-015-3712-y
  2. Antimicrobial effect of Malaysian vegetables against enteric bacteria vol.6, pp.3, 2016, https://doi.org/10.1016/j.apjtb.2015.12.009
  3. Phytochemicals in Helicobacter pylori Infections: What Are We Doing Now? vol.19, pp.8, 2018, https://doi.org/10.3390/ijms19082361
  4. Licorice extract suppresses adipogenesis through regulation of mitotic clonal expansion and adenosine monophosphate‐activated protein kinase in 3T3‐L1 cells vol.44, pp.12, 2013, https://doi.org/10.1111/jfbc.13528
  5. Vegetable Extracts and Nutrients Useful in the Recovery from Helicobacter pylori Infection: A Systematic Review on Clinical Trials vol.26, pp.8, 2013, https://doi.org/10.3390/molecules26082272